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Seizures were the presenting clinical symptom in 10 (12%) of 81 consecutive children with a primary brain tumour treated in
a tertiary paediatric oncology unit over 5 years. Nine patients experienced partial seizures, and in seven a waking electroen-
cephalogram showed focal or lateralising abnormalities. Astrocytoma was the most common tumour histology. The delay in
tumour diagnosis from the onset of seizures ranged from 2 weeks to 2 years with a mean of 6 months. Complete resection of the
tumour was the only treatment in three patients and four underwent resection followed by radiotherapy and/or chemotherapy.
Two patients died. Three patients became seizure free receiving no antiepileptic medication and the remaining five showed a
50–80% reduction in seizures between 2 and almost 5 years following treatment.
© 2003 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Brain tumours are one of the most common solid
tumours in children, with an incidence of approx-
imately 1–5 per 100 0001. In the UK, the annual
incidence in children under 15 years is 3 per 100 000
(350 cases annually)2. Presentation is usually with
symptoms and signs of raised intracranial pressure
with or without evidence of cranial nerve dysfunc-
tion, reflecting the fact that most brain tumours in
children over 4 years of age are sited infratentori-
ally and specifically within the posterior fossa or
brainstem2–5. Supratentorial tumours are more com-
mon in children under 4 years of age and in adults.
Although cognitive or behavioural difficulties may
also be presenting features of brain tumours that are
located supratentorially (typically within the frontal or
temporal lobes), seizures are a relatively uncommon
presentation of brain tumours. Previous studies have
primarily focused on specific epilepsy populations
and the proportion of epilepsy being caused by brain
tumours, where the reported frequency is 0.2–6%,
depending on the type of seizure6, 7. Studies that have
examined the frequency of epilepsy as the initial pre-
sentation of a brain tumour in children have reported
a wide range of rates, from 7–16%4, 5, 8–11 to as high
as 40%12.
The purpose of this retrospective study is to review
the detailed seizure history of a population of children
with brain tumours.
METHODS
The case notes were reviewed retrospectively of all
children aged 1 month to 15 years presenting with a
primary brain tumour to a regional paediatric oncology
unit in a tertiary care Children’s Hospital over 5 years.
Children with secondary (metastatic) brain disease and
with a haematological malignancy were excluded from
this review. The paediatric oncology unit serves a total
population of 2.8 million and is the only paediatric
unit in the region that manages and co-ordinates the
care of children with brain tumours.
Information was collected on the following: sex, age
at onset of seizures, age at diagnosis of brain tumour,
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type or types of seizures, additional neurological,
cognitive or behavioural symptoms or signs at time
of seizure onset, electroencephalographic (EEG) find-
ings, magnetic resonance imaging (MRI) findings,
histology of the tumour, treatment of the tumour, years
of follow-up and seizure outcome (seizure frequency
at latest follow-up compared to seizure frequency at
time of tumour diagnosis).
Surface (scalp) EEG was undertaken in either
the waking or drowsy (following sleep deprivation)
state with a Micromed ‘Brain Quick’ 32 System 98
using the international 10–20 electrode placement
with referential and bipolar montages and reported
by one paediatric neurologist/neurophysiologist.
In-depth EEG monitoring and intra-operative electro-
corticography (ECOG) were not undertaken in any
patient.
MRI was undertaken using a Philips 0.5T Gyroscan
NT 5 scanner, with axial and coronal views employ-
ing T1, T2 and FLAIR sequences with and without
gadolinium and interpreted by two paediatric neuro-
radiologists.
RESULTS
Eighty-one patients were diagnosed with a primary
brain tumour between January 1996 and December
2000. Ten of the 81 patients (12.3%) presented with
epilepsy. The tumour was sited supratentorially in
all 10 patients. Demographic, treatment and seizure
outcome details are demonstrated in Table 1. Neuro-
logical examination was normal in 7 of the 10 pa-
tients; 1 patient had a slight hemiparesis and another
patient demonstrated behavioural changes (impulsiv-
ity and disinhibition) that had ante-dated the seizures
by a number of months. One patient had precocious
puberty and one patient each had tuberous sclerosis
(TS) and neurofibromatosis (NF). The patient with
TS (Patient 3) demonstrated developmental delay at
the time infantile spasms and partial seizures were
diagnosed at 13 months of age; the patient with NF
(Patient 10) already showed global developmental
delay and abnormal visual behaviour when infantile
spasms were diagnosed at 6 months of age. Patient 3
became seizure free on vigabatrin and re-presented at
8.5 years with complex partial and secondarily gen-
eralised tonic–clonic seizures. Repeat MRI showed a
subependymal giant cell astrocytoma (SEGA). Patient
10 presented at 6 months of age with infantile spasms
and MRI showed an optic nerve glioma involving the
optic chiasm and an enlarged, dysplastic-looking left
temporal lobe. Complex partial and secondarily gen-
eralised seizures developed and were resistant to all
antiepileptic drugs (AEDs). Sequential MRI revealed
progressive expansion of the left temporal lobe and a
subsequent temporal lobectomy revealed a low-grade
glioma.
The mean age at onset of seizures was 5.7 years
and the mean age at diagnosis of the tumour was 6.1
years. The duration of epilepsy prior to the diagnosis
of the tumour ranged from 1 to 2 weeks (Patients 4
and 7, respectively) to 2 years with a mean of 0.5
years in the remaining eight patients. The longest
period of active epilepsy prior to the diagnosis of a
tumour was 2 years (Patient 6) whose initial (com-
puterised tomography [CT]) brain scan performed
3 months after seizure onset was reported to be
normal.
Seizures were occurring at least weekly in all 10
patients prior to the diagnosis of the tumour; in 7 the
seizures were occurring at least once daily, including
in Patient 6, where seizures had been occurring for 2
years prior to the diagnosis of the tumour.
Six patients were receiving one, and three pa-
tients, two drugs at the time the tumour was diag-
nosed. Monotherapy included carbamazepine (three
patients), vigabatrin (two patients) and lamotrigine
(one patient). Dual therapy included one patient with
each of the following combinations: carbamazepine+
phenytoin, carbamazepine + vigabatrin and vigabat-
rin + clobazam. One family declined any medication
after the first AED proved ineffective and prior to
treatment of the tumour (Patient 7).
No patient had developed any new neurological
deficit following surgery. Pre- and post-operative vi-
sual field examination was not performed routinely
and it is therefore not possible to comment on whether
surgery may have caused any new or additional visual
field defects.
Resection of the tumour was undertaken in seven
patients, in whom it was radical in five (Patients 3, 5,
7, 9 and 10). Patients 2 and 4 required additional re-
sections because of persistent clinical seizures rather
than because of tumour recurrence. The diagnosis
was made by high resolution MRI without histolog-
ical diagnosis in Patient 1; in Patient 6, histology
was confirmed by biopsy with no resection due to
tumour location. Resection was considered inap-
propriate in Patient 8 in view of the biopsy-proven
histological diagnosis of a high-grade and malignant
tumour.
At the time of the latest follow-up, three patients had
remained seizure free and receiving no AED between
2 and 3.5 years after treatment of the tumour. Two pa-
tients died, both with persisting seizures at the time of
death. The remaining five children continue to expe-
rience seizures but in all there has been a 50 to 80%
reduction in seizure frequency, particularly secondar-
ily generalised tonic–clonic seizures. Three of these
five patients are receiving one, and the remaining two
patients, two AEDs.
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Table 1: Demographic features of the 10 patients
Patient no. (sex) Age at onset of Age at diagnosis of Seizure types(s) Neurological/physical signs EEG findings Tumour type Tumour treatment Years of Current seizure
seizures (years) tumour (years) at time of seizure onset follow-up status
1. (M) 7.9 8.0 CP; gelastic Early precocious puberty Left temporal
spike
Hypothalamic
hamartoma
Nil 3.2 Monthly#
2. (F) 12.7 13.0 Myoclonic None N Astrocytoma
(grade 1, left
temporal lobe)
Resection (×2)
chemotherapy
(×2)
3.6 Every 2–3
months#
3. (F) 1.1 (9)∗ 10.0 Infantile spasms;
(CP; SGTC)∗
Tuberous sclerosis Right frontal
spike
SEGA Resection 4.2 Weekly#
4. (F) 1.4 1.4 SP; CP; SGTC Minimal right hemiparesis Left frontal
spike
Oligodendroglima
(grade 2, left
frontal lobe)
Resection (×3)
chemotherapy
(×2)
1.8 Seizure free
(no anti-epileptic
medication)
5. (M) 3.1 3.8 SP; SGTC None Right temporal
spike
DNET (right
temporal lobe)
Resection 2.2 Every 2–3 weeks#
6. (F) 5.7 7.7 CP None N Astrocytoma
(grade 2, right
temporal lobe)
Chemotherapy 2.8 Seizure free
(no anti-epileptic
medication)
7. (F) 6.9 6.9 CP None ND PNET (right
parietal lobe)
Resection
radiotherapy
chemotherapy
3.4 Seizure free
(no anti-epileptic
medication)
8. (F) 8.5 8.6 SP; CP Behaviour change Left
frontotemporal
spike
Astrocytoma
(anaplastic,
left frontal
lobe)
Nil – Died aged 9.5 yrs
9. (M) 1.1 1.3 SP; CP; SGTC None Left temporal
sharp wave
Astrocytoma
(grade 2, left
temporal lobe)
Resection 4.7 Weekly#
10. (M) 0.6 0.7 Infantile spasms
CP
Neurofibromatosis Hyps; left
temporal spike
Optic nerve
glioma; left
temporal
glioma
Resection
(temporal lobe
chemotherapy)
– Died aged 5 yrs
CP = complex partial; SGTC = secondarily generalised tonic-clonic; SP = simple partial; SEGA = subependymal giant cell astrocytoma; DNET = dysembryoblastic neuroepithelial tumour;
PNET= primitive neuroectodermaltumour; N = normal; ND = not done; Hyps = hypsarrhythmia.
∗ presented at 13 months with infantile spasms; re-presented at 9 years with partial and secondarily generalised seizures.
# seizures persist but > 50% reduction in seizure frequency of all seizure types compared to seizure frequency prior to tumour diagnosis.
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DISCUSSION
Approximately one in nine (12%) of our patients
presented with seizures as the first symptom of an
underlying brain tumour. This is similar5, 8–10 or al-
most identical11 to previous paediatric studies, but
almost one half of adult studies9, 12. The study by
Low et al. reported a very high incidence of seizures
(49 of 123 children, 40%) but it was unclear whether
this related to the initial presenting symptom or to
all patients who experienced a seizure at any time
during their study13. The increased rate in adults is
likely to reflect the fact that proportionately, most
brain tumours in adults are supratentorial and sited
in the cerebral hemispheres. Most of the tumours in
our series were low-grade gliomas or astrocytomas,
tumours that are commonly seen in children and
which are recognised to cause seizures2, 8, 14, 15. One
patient each had a dysembryoplastic neuroepithelial
tumour (DNET), primitive neuroectodermal tumour
(PNET) and oligodendroglioma, tumour types that
are also known to cause epilepsy. Somewhat surpris-
ingly, neither DNETs nor PNETs were found to be
associated with epilepsy in an earlier and slightly
larger paediatric series15, in contrast to a very recent
series of 23 patients with intractable epilepsy caused
by brain tumours11, in which DNETs accounted for
9 of 23 tumours. Tumour series reported prior to
1973/1974 would not have included PNETs, as this
type was only introduced to tumour classifications
after this time16; previously, these tumours were usu-
ally labelled ‘cerebral neuroblastomas’. Although
there is some debate as to whether DNETs should be
regarded as a tumour, the most recent World Health
Organisation (WHO) classification includes them
in the category of ‘neuronal and mixed neuroglial
tumours’17, 18.
The two children with a neurocutaneous syndrome
(TS and NF) developed characteristic tumour types
known to occur in these disorders. The presentation
with seizures of the patient with TS who developed
a SEGA was atypical; the more usual presentation
of this tumour is with symptoms and signs of hy-
drocephalus. The course of the patient with NF was
also atypical, firstly in terms of the initial presentation
with infantile spasms and secondly with the subse-
quent development and rapid growth of the temporal
glioma.
Most of the patients were found to have a brain tu-
mour within 3 or 4 months of the onset of seizures.
This is considerably shorter than has been found in
previous studies, where the lag time between seizure
onset and tumour diagnosis has been as short as 3
weeks and as long as almost 10 years, but typically
with a mean duration of 1–3 years4, 5, 8, 9, 15. Previous
studies that have evaluated the relationship of epilepsy
and brain tumours have reasonably suggested that the
presence of focal neurological signs may contribute to
an earlier diagnosis of the tumour. In our series, 6 of
the 10 patients had neither focal neurological signs nor
a history of either cognitive or behavioural difficulties.
In children with supratentorial tumours and particu-
larly in those with tumours of the temporal lobes, fo-
cal neurological abnormalities and fundoscopic signs
of increased intracranial pressure usually develop late.
Behavioural and cognitive difficulties, additional fea-
tures of tumours within the cerebral hemispheres, may
also be identified—and taken seriously—only after
many months.
The EEG may clearly be useful in suggesting a struc-
tural abnormality, particularly in children with simple
and complex partial seizures; however, the correlation
between focal EEG findings and structural lesions is
neither close nor consistent19. Previous reports have
shown that focal or lateralising abnormalities occur
in between 808, 8215 and 92%5 of children who have
seizures and brain tumours within the cerebral hemi-
spheres. At least one report has suggested that the
initial EEG, as distinct from repeated EEGs, may be
of no localising value in adult patients with chronic
epilepsy due to slow growing brain tumours20. Seven
of the patients (70%) in the present series had focal
EEG changes, which together with the partial semiol-
ogy of the seizures, would have resulted in early neu-
roimaging based on the local guidelines of when to
undertake brain scans in children with epilepsy. These
guidelines, in common with international guidelines21,
also recommend that MRI should be undertaken in all
children with infantile spasms. Adherence to our lo-
cal neuroimaging guidelines may be one explanation
for the relatively early identification of the tumours in
our patients.
Few previous reports have evaluated the long-term
seizure outcome in children with brain tumours. Of
the 15 patients reported by Patel et al.15, 80% showed
a ‘very significant’ improvement in seizure frequency,
with 8 becoming seizure free and 4 experiencing only
‘rare’ seizures, based on the Engel classification22. In
the earlier study of Sjors et al.8, which did not state
the duration of follow-up, 8 of the 10 patients who sur-
vived were seizure free, 5 on antiepileptic medication.
Eight of our patients survived, of whom three became
seizure free and receiving no antiepileptic medication
and the remaining 5 showed a reduction in seizure
frequency of between 50 and 80% at the time of the
most recent follow-up (approximately 2–5 years after
the diagnosis of the tumours). There may be a number
of reasons for the relatively poor seizure outcome in
our patients compared to earlier studies8, 15, including
tumour histology, the extent of surgical resection and
late complications of chemotherapy and radiotherapy.
The duration of seizures is unlikely to have been a
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contributory factor as the delay in diagnosis of the
tumour was considerably shorter in our patients than
in earlier studies8, 14. It is likely that intra-operative
EEG monitoring with ECOG may have allowed a
more precise surgical resection that could have poten-
tially influenced seizure outcome. It is also possible
that lesionectomy (resecting only the macroscopically
visible limits of the tumour) may not be as effective
as a more radical resection that removes not only the
tumour but also any additional epileptogenic tissue
around the tumour11. Unfortunately, the numbers of
patients in the present, and previous8, 11, 15, studies
are too small to try and correlate seizure outcome
with tumour histology, delay in tumour diagnosis,
extent of tumour resection or additional treatments
(radiotherapy and chemotherapy). The influence on
long-term seizure outcome of some of these factors
could potentially only be clarified by national or even
international collaborative studies.
CONCLUSION
Seizures are an uncommon presentation of brain tu-
mours in children, occurring in approximately 10%
of cases and are rarely accompanied by focal neu-
rological signs, particularly in older children. The
semiology of the seizures are typically partial and
the presence of focal or lateralising EEG abnor-
malities which do not suggest one of the idiopathic
partial epilepsy syndromes, should lead to early
consideration of neuroimaging, specifically with
MRI.
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